Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.
School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland.
J Infect Dev Ctries. 2024 Apr 30;18(4):504-512. doi: 10.3855/jidc.19255.
The coronavirus disease 2019 (COVID-19) pandemic affected antibiotic usage worldwide. However, there is limited data from Serbia. Dispensing of oral antibiotics in Serbian pharmacies was analyzed to calculate monthly and yearly changes between 2018-2021, and to explore immediate and long-term effects of COVID-19 on antibiotic dispensing during this period.
The number of antibiotic packages dispensed from pharmacies during the study period was analyzed with a Chi-square test to assess the average change in annual dispensing, and an interrupted time-series analysis was used to evaluate the impact of the pandemic on antibiotic dispensing. The data from 2018-2021 were retrieved from the database of a large community pharmacy chain in Serbia.
The average number of antibiotic packages dispensed per day and per pharmacy was higher in 2021 compared to 2018 by one package. However, the dispensing of macrolides increased significantly; 17.7% (2018) vs. 22.5% (2021) (p < 0.05). In general, an increase in antibiotic dispensing was detected during COVID-19 for total antibiotics (16.4%), Watch antibiotics (44.8%), third-generation cephalosporins (80.4%), macrolides (45.5%) and azithromycin (83.7%). However, the immediate effect of COVID-19 was a decrease in the dispensing of Watch antibiotics, penicillin, and third-generation cephalosporins (p < 0.05); and a notable long-term COVID-19 effect was an increase in the dispensing of azithromycin (p < 0.05).
In spite of a relatively stable trend of total antibiotic dispensing before and during COVID-19 pandemic, the use of Watch antibiotics, third-generation cephalosporins, and macrolides (particularly azithromycin) showed an increasing trend in dispensing that should be optimized.
2019 年冠状病毒病(COVID-19)大流行影响了全球的抗生素使用。然而,来自塞尔维亚的数据有限。分析了塞尔维亚药店的口服抗生素配药情况,以计算 2018-2021 年期间的每月和每年变化,并探讨 COVID-19 在这期间对抗生素配药的即时和长期影响。
使用卡方检验分析研究期间从药店配出的抗生素包数,以评估年配药量的平均变化,并使用中断时间序列分析评估大流行对抗生素配药的影响。2018-2021 年的数据从塞尔维亚一家大型社区连锁药店的数据库中检索。
与 2018 年相比,2021 年每天和每家药店配出的抗生素包数平均增加了一包。然而,大环内酯类药物的配药量显著增加;2018 年为 17.7%,2021 年为 22.5%(p<0.05)。总体而言,在 COVID-19 期间,抗生素的配药量增加,总抗生素(16.4%)、监测抗生素(44.8%)、第三代头孢菌素(80.4%)、大环内酯类(45.5%)和阿奇霉素(83.7%)。然而,COVID-19 的即时影响是监测抗生素、青霉素和第三代头孢菌素的配药量减少(p<0.05);COVID-19 的长期显著影响是阿奇霉素的配药量增加(p<0.05)。
尽管在 COVID-19 大流行前后,抗生素总配药量呈相对稳定趋势,但监测抗生素、第三代头孢菌素和大环内酯类(尤其是阿奇霉素)的使用呈配药量增加趋势,应加以优化。